US 11865148
Methods of delivering transgenes to the eye
granted A61KA61K35/763A61K38/1748
Quick answer
US patent 11865148 (Methods of delivering transgenes to the eye) held by Krystal Biotech, Inc. expires Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Krystal Biotech, Inc.
- Grant date
- Tue Jan 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K35/763, A61K38/1748, A61K38/39, A61K47/38